Ensysce Biosciences Posts Q1 Loss

Ensysce Biosciences reports Q1 GAAP EPS of -$0.52 Ensysce Biosciences reported a Q1 GAAP EPS of -$0.52, beating by $0.21. The company received federal grants of $0.96M, a 27.3% year-over-year decrease, missing by $0.94M. The company's cash and cash equivalents